Literature DB >> 27561721

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Suzanna M van Walraven1,2, Anneke Brand2,3, Jack N A Bakker4, Martin B A Heemskerk5, Suzan Nillesen6, Marc B Bierings7, Laura B Bungener8, Bouke G Hepkema8, Arjan Lankester9, Arnold van der Meer6,10, Kees Sintnicolaas11, Judith A E Somers11, Eric Spierings12, Marcel G J Tilanus13, Christien E M Voorter13, Jan J Cornelissen14, Machteld Oudshoorn4,3.   

Abstract

Between 2001 and 2012, the number of unrelated donors registered worldwide increased from 7 to 21 million, and the number of public cord blood units increased to over 500,000. We addressed the question of whether this expansion resulted in higher percentages of patients reaching transplantation. Unrelated donor searches were evaluated for 3,124 eligible patients in the Netherlands in two cohorts (2001-2006, n=995; 2007-2012, n=2129), comparing results for patients of Northwestern European and non-Northwestern European origin. Endpoints were 'donor found' and 'transplantation reached'. The substantial growth of the donor inventory over the period studied did not increase the median number of potential unrelated donors (n=7) for non-Northwestern European patients, but almost doubled the number for Northwestern European patients from 42 to 71. Before and after 2007, an unrelated donor or cord blood was identified for 91% and 95%, respectively, of Northwestern European patients and for 65% and 82% of non-Northwestern European patients (P<0.0001). Non-Northwestern European patients more often needed a cord blood transplant. The degree of HLA matching was significantly lower for non-Northwestern European patients (P<0.0006). The time needed to identify a donor decreased for both populations. The percentage of Northwestern European patients reaching transplantation increased from 77% to 83% and for non-Northwestern European patients from 57% to 72% (P=0.0003). The increase of the global inventory resulted in more transplants for patients lacking a family donor, although the quality and quantity of (potential) haematopoietic cell grafts for patients of a non-Northwestern European descent remained inferior, indicating the need for adaptation of recruitment. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Year:  2016        PMID: 27561721      PMCID: PMC5210248          DOI: 10.3324/haematol.2016.145730

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  38 in total

1.  Hematopoietic stem cell transplantation: a global perspective.

Authors:  Alois Gratwohl; Helen Baldomero; Mahmoud Aljurf; Marcelo C Pasquini; Luis Fernando Bouzas; Ayami Yoshimi; Jeff Szer; Jeff Lipton; Alvin Schwendener; Michael Gratwohl; Karl Frauendorfer; Dietger Niederwieser; Mary Horowitz; Yoshihisa Kodera
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

2.  Filling the gaps - the generation of full genomic sequences for 15 common and well-documented HLA class I alleles using next-generation sequencing technology.

Authors:  C Lind; D Ferriola; K Mackiewicz; A Papazoglou; A Sasson; D Monos
Journal:  Hum Immunol       Date:  2012-12-13       Impact factor: 2.850

3.  Ethnicity, length of time on the register and sex predict donor availability at the confirmatory typing stage.

Authors:  R N Lown; S G E Marsh; G E Switzer; K A Latham; J A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-01-13       Impact factor: 5.483

Review 4.  Racial disparities in hematopoietic cell transplantation in the United States.

Authors:  N S Majhail; S Nayyar; M E Burton Santibañez; E A Murphy; E M Denzen
Journal:  Bone Marrow Transplant       Date:  2011-11-07       Impact factor: 5.483

5.  Computer program to predict likelihood of finding and HLA-matched donor: methodology, validation, and application.

Authors:  M Mori; M Graves; E L Milford; P G Beatty
Journal:  Biol Blood Marrow Transplant       Date:  1996-10       Impact factor: 5.742

6.  Race and ethnicity in decisions about unrelated hematopoietic stem cell donation.

Authors:  Galen E Switzer; Jessica G Bruce; Larissa Myaskovsky; Andrea DiMartini; Diana Shellmer; Dennis L Confer; Linda K Abress; Roberta J King; Allyson G Harnaha; Sibylle Ohngemach; Mary Amanda Dew
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

7.  HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry.

Authors:  Loren Gragert; Mary Eapen; Eric Williams; John Freeman; Stephen Spellman; Robert Baitty; Robert Hartzman; J Douglas Rizzo; Mary Horowitz; Dennis Confer; Martin Maiers
Journal:  N Engl J Med       Date:  2014-07-24       Impact factor: 91.245

8.  Selective recruitment of stem cell donors with rare human leukocyte antigen phenotypes.

Authors:  A H Schmidt; A Stahr; D Baier; S Schumacher; G Ehninger; C Rutt
Journal:  Bone Marrow Transplant       Date:  2007-08-27       Impact factor: 5.483

9.  HLA allele and haplotype polymorphisms among Croatian patients in an unrelated hematopoietic stem cell donor search program.

Authors:  Zorana Grubic; Katarina Stingl Jankovic; Marija Maskalan; Ranka Serventi-Seiwerth; Mirta Mikulic; Marija Burek Kamenaric; Damir Nemet; Renata Zunec
Journal:  Transpl Immunol       Date:  2014-06-27       Impact factor: 1.708

10.  Cost effectiveness of cord blood versus bone marrow and peripheral blood stem cells.

Authors:  Thomas Bart
Journal:  Clinicoecon Outcomes Res       Date:  2010-10-05
View more
  4 in total

1.  Multimedia resources to support the recruitment of committed hematopoietic stem cell donors: Perspectives of the most-needed donors.

Authors:  Edward W Li; Anna Lee; Maryam Vaseghi-Shanjani; Alexander Anagnostopoulos; Gabriele Jagelaviciute; Elena Kum; Tanya Petraszko; Heidi Elmoazzen; David Allan; Warren Fingrut
Journal:  Transfusion       Date:  2020-12-02       Impact factor: 3.157

2.  Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations.

Authors:  Kirsten Geneugelijk; Kirsten A Thus; Hanneke W M van Deutekom; Jorg J A Calis; Eric Borst; Can Keşmir; Machteld Oudshoorn; Bronno van der Holt; Ellen Meijer; Sacha Zeerleder; Marco R de Groot; Peter A von dem Borne; Nicolaas Schaap; Jan Cornelissen; Jürgen Kuball; Eric Spierings
Journal:  Front Immunol       Date:  2019-04-24       Impact factor: 7.561

Review 3.  Immunogenetics in stem cell donor registry work: The DKMS example (Part 2).

Authors:  Alexander H Schmidt; Jürgen Sauter; Daniel M Baier; Jessica Daiss; Andreas Keller; Anja Klussmeier; Thilo Mengling; Gabi Rall; Tobias Riethmüller; Gerhard Schöfl; Ute V Solloch; Tigran Torosian; David Means; Helen Kelly; Latha Jagannathan; Patrick Paul; Anette S Giani; Sabine Hildebrand; Stephan Schumacher; Jan Markert; Monika Füssel; Jan A Hofmann; Thomas Schäfer; Julia Pingel; Vinzenz Lange; Johannes Schetelig
Journal:  Int J Immunogenet       Date:  2020-02-07       Impact factor: 1.466

4.  Ensuring HLA-matched platelet support requires an ethnic diverse donor population.

Authors:  Aukje L Kreuger; Geert W Haasnoot; Judith A E Somers; Bert Tomson; Johanna G van der Bon; Marian G J van Kraaij; Claudia M Weller
Journal:  Transfusion       Date:  2020-02-22       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.